HK1178792A1 - Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract - Google Patents

Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract

Info

Publication number
HK1178792A1
HK1178792A1 HK13105841.5A HK13105841A HK1178792A1 HK 1178792 A1 HK1178792 A1 HK 1178792A1 HK 13105841 A HK13105841 A HK 13105841A HK 1178792 A1 HK1178792 A1 HK 1178792A1
Authority
HK
Hong Kong
Prior art keywords
plant tissue
dried
extract
tissue extract
beverage
Prior art date
Application number
HK13105841.5A
Other languages
Chinese (zh)
Inventor
大泉康
山國徹
川畑伊知郎
吉田雅昭
Original Assignee
小太郎漢方制藥株式會社
國立大學法人東北大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 小太郎漢方制藥株式會社, 國立大學法人東北大學 filed Critical 小太郎漢方制藥株式會社
Publication of HK1178792A1 publication Critical patent/HK1178792A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13105841.5A 2010-02-26 2013-05-16 Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract HK1178792A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2010042819 2010-02-26
JP2010126717 2010-06-02
JP2010270578 2010-12-03
PCT/JP2011/054358 WO2011105568A1 (en) 2010-02-26 2011-02-25 Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning/memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract

Publications (1)

Publication Number Publication Date
HK1178792A1 true HK1178792A1 (en) 2013-09-19

Family

ID=44506965

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13105841.5A HK1178792A1 (en) 2010-02-26 2013-05-16 Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract

Country Status (4)

Country Link
JP (2) JP5503726B2 (en)
CN (1) CN102883716B (en)
HK (1) HK1178792A1 (en)
WO (1) WO2011105568A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103930106A (en) * 2012-06-21 2014-07-16 小太郎汉方制药株式会社 Composition for improving and/or treating central nervous system degenerative disease
CN103479743B (en) * 2013-01-28 2015-07-08 钱昌美 Pharmaceutical composition for treating senile dementia and preparation method thereof
JP6179891B2 (en) * 2013-05-29 2017-08-16 要 有持 Production methods, processing methods, processed products and tea
JP2015053939A (en) * 2013-09-10 2015-03-23 久子 松野 Processed food of skin of orange
WO2015199118A1 (en) * 2014-06-26 2015-12-30 日本ゼオン株式会社 Method for promoting phosphorylation of erk or akt in cultured cell, cell culture method, and phosphorylation promoter
JP2016056149A (en) * 2014-09-11 2016-04-21 日油株式会社 Skin cosmetic
KR102005273B1 (en) * 2014-11-12 2019-07-30 주식회사 파마코렉스 Medicinal composition for preventing or improving dysuria, antagonist against dysuria-related receptor, and method for preventing or improving dysuria using medicinal composition or antagonist
JP6238089B1 (en) * 2016-06-01 2017-11-29 株式会社三協ホールディングス Pharmaceutical composition and food
JP6898628B2 (en) * 2016-06-15 2021-07-07 国立大学法人広島大学 Neurodegenerative disease therapeutic agent
CN107648349A (en) * 2017-10-30 2018-02-02 江西中医药大学 Bitter orange flower is preparing the application in improving sleep-disorder or improving failure of memory or treat Alzheimer disease drugs or health food
WO2019102602A1 (en) * 2017-11-27 2019-05-31 康 大泉 Screening method
KR101894491B1 (en) * 2018-04-30 2018-09-04 주식회사 뉴트라팜텍 A composition for improving memory or cognitive function comprising a aurantii fructus immaturus supercritical extract as an active ingredient
CN112402409A (en) * 2020-12-11 2021-02-26 江汉大学 Application of hesperetin in preparation of drugs for inhibiting beta-secretase activity
CN115886258B (en) * 2022-12-30 2024-07-05 上海交大昂立股份有限公司 Composite probiotic composition for improving physiological memory attenuation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053152A1 (en) * 2001-01-08 2002-07-11 Imperial College Of Science, Technology & Medicine Composition containing flavonoids for treatment brain disorders
JP2008127325A (en) * 2006-11-20 2008-06-05 Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan Phosphorylated mbp production promoter

Also Published As

Publication number Publication date
JP5906267B2 (en) 2016-04-20
CN102883716B (en) 2014-05-07
JPWO2011105568A1 (en) 2013-06-20
CN102883716A (en) 2013-01-16
WO2011105568A1 (en) 2011-09-01
JP2014111664A (en) 2014-06-19
JP5503726B2 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
HK1178792A1 (en) Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract
HK1259355A1 (en) 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same
FR2953135B1 (en) MACROSTACHYA ACACIA SEED EXTRACT AND COSMETIC, PHARMACEUTICAL, DERMATOLOGICAL, NUTRACEUTICAL OR FOOD COMPOSITIONS COMPRISING THE SAME
AP2013006921A0 (en) Aminoalcohol substituted 2,3-dihydroimidazol[1,2-CÜquinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
PL2940124T3 (en) Novel lactic acid bacterium, drug, food or drink, and feed which contain the novel lactic acid bacterium
EP2114421A4 (en) Bacterial extract for respiratory disorders and proces for its preparation
WO2012035479A3 (en) Spinal fixation system and pedicle screw therefor
WO2012125981A3 (en) Raf kinase inhibitors
WO2015143447A3 (en) Methods for treating neurological disorders
HK1204320A1 (en) 6,7-dihydro-5h-benzo[7]annulene derivatives, methods for the production thereof, pharmaceutical preparations that contain said 6,7-dihydro-5h-benzo[7]annulene derivatives, and use thereof to produce drugs 67--5h-[7] 67--5h- [7]
PL2173195T3 (en) Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
EP2438927A4 (en) Pharmaceutical composition, food or beverage, and methods for these products
IL217293A0 (en) NOVEL 1,2,3,4 - TETRAHYDROPYRIMIDO {1,2-a} PYRIMIDIN - 6 - ONE DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF
PT2448939T (en) 2,3-dihydro-1h-imidazo {1,2-a} pyrimidin-5-one derivatives, the preparation and pharmaceutical use thereof
HK1172321A1 (en) 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use 3--8--3h [51-d][1235]--4-
EP2608786A4 (en) Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
HK1197235A1 (en) Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
EP2305268A4 (en) A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe
EP2402333A4 (en) 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
EP2723325A4 (en) Novel formulations and methods for treating dermatological disorders or diseases
EP2727599A4 (en) Pharmaceutical composition and food composition for preventing and ameliorating intestinal motility disorders
EP2582832A4 (en) Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders
BR112012009351A2 (en) method for the prevention or treatment of disorders, use of a solanum glaucophyllum plant extract, dietary or dietary composition, dietary supplement, food or supplement
EP2789613A4 (en) 1, 4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof
Fields The psychology of pain